Menu
  • The inaugural holding of the US E-Cigarette Summit will take place in Washington DC, on Monday May 8, 2017
  • Registration for the US E-Cigarette Summit 2017 is now open

Dr. Kevin Walton PhD

Chief, Clinical Research Grants Branch, Division of Therapeutics and Medical Consequences
(NIDA) National Institute on Drug Abuse, NIH

Dr. Kevin Walton is the Chief of the Clinical Research Grants Branch in the Division of Therapeutics and Medical Consequences at the National Institute on Drug Abuse at the National Institutes of Health. His branch is responsible for leading the grant-funded clinical research exploring new medication, behavioral, and device development for the treatment of substance use disorders, including smoking cessation. After a position as an Assistant Professor at the University of Michigan, Dr. Walton spent 15 years in neuroscience drug discovery in the biotech and pharmaceutical industries where he worked on developing novel medications for both neurological and psychiatric disorders.  He has been at NIH since 2010 and joined NIDA in 2013. Dr. Walton received his PhD in Pharmacology at the Johns Hopkins University School of Medicine.

Dr. Kevin Walton PhD will be speaking at:

E-Cigarettes and Health Research

- 14:05 - 14:20

Open Floor Q&A and Moderated Discussion

- 14:50 - 15:15

« Back to previous page